ArticleEmerging infectious diseases2024

Hepatitis B Virus Reactivation after Switch to Cabotegravir/Rilpivirine in Patient with Low Hepatitis B Surface Antibody.

Eisuke Adachi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.